We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sympathetic Overactivity in Essential Hypertension

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00541619
Recruitment Status : Withdrawn (No patients could be recruited.)
First Posted : October 10, 2007
Last Update Posted : April 17, 2013
Sponsor:
Information provided by (Responsible Party):
University of Erlangen-Nürnberg Medical School

Brief Summary:
The primary objective of the study is whether subjects with hypertension and proteinuria display increased sympathetic nerve activity compared to hypertensive subjects without proteinuria and normotensive controls.

Condition or disease
Hypertension Proteinuria

Study Type : Observational
Actual Enrollment : 0 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Sympathetic Overactivity in Essential Hypertension
Study Start Date : October 2007
Primary Completion Date : March 2011
Study Completion Date : March 2011

Group/Cohort
A
hypertensives with proteinuria




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Patients with primary hypertension.
Criteria

Inclusion Criteria:

  • Normotension or hypertension

Exclusion Criteria:

  • Pregnant and nursing women
  • Myocardial infarction, clinical signs of coronary heart disease
  • Severe depression

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00541619


Locations
Germany
Nephrology and Hypertension, Clinical Research Center
Erlangen, Bavaria, Germany, 91054
Sponsors and Collaborators
University of Erlangen-Nürnberg Medical School
Investigators
Principal Investigator: Roland Veelken, MD Principal Investigator

Responsible Party: University of Erlangen-Nürnberg Medical School
ClinicalTrials.gov Identifier: NCT00541619     History of Changes
Other Study ID Numbers: RE-No.3210
First Posted: October 10, 2007    Key Record Dates
Last Update Posted: April 17, 2013
Last Verified: April 2013

Keywords provided by University of Erlangen-Nürnberg Medical School:
hypertension
sympathetic activity
early renal damage

Additional relevant MeSH terms:
Hypertension
Proteinuria
Vascular Diseases
Cardiovascular Diseases
Urination Disorders
Urologic Diseases
Urological Manifestations
Signs and Symptoms